Skip to content
All Sections
Subscribe Now
74°F
Wednesday, October 1st 2025
e-Edition
Home Page
News
News
Crime and Public Safety
Investigative Reporting
Election
Politics
Health
Environment
Business
Best Reviews
Housing
Jobs
Weather
Local News
Local News
Ontario
Pomona
Chino Valley
Rancho Cucamonga
Claremont
Montclair
Upland
La Verne
San Bernardino County
Los Angeles County
David Allen Column
Sports
Sports
IE Varsity
Chargers
Rams
Lakers
Clippers
Dodgers
Angels
College Sports
UCLA Sports
USC Sports
Kings
Ducks
Olympics
Boxing/MMA
Soccer
Horse Racing
Things To Do
Things To Do
Restaurants Food and Drink
Casinos
Amusement Parks
Movies
Music + Concerts
Theater
TV and Streaming
Home + Garden
Travel
Comics
Events
Obituaries
Obituaries
News Obituaries
Place an Obituary
Opinion
Opinion
Editorials
Opinion Columns
Commentary
Letters to the Editor
Editorial Board
Endorsements
SCNG Premium
Branded Content
Paid Content by Brandpoint
Sponsored Content
The T.E.A.
Subscribe
Daily Bulletin Store
Log In
Logout
Get the latest news delivered daily!
Sign Up
Subscribe
Log In
Account Settings
Contact Us
Log Out
Spoof a user
Get the latest news delivered daily!
Sign Up
Subscribe
Log In
Search
74°F
Wednesday, October 1st 2025
e-Edition
News
Local News
Sports
Obituaries
Things to Do
Opinion
The T.E.A.
Trending:
IE doctor shortageð
Ontario baseball team's name
High school football ð
Oktoberfest ðº
Immigration news
Trump news
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Latest News about Phase 2 Trial
Recent news which mentions Phase 2 Trial
< Previous
1
2
3
4
5
6
7
8
9
Next >
ASLAN Pharma Kickstarts Mid-Stage Atopic Dermatitis Trial, Data Expected In 2023
January 21, 2022
Tickers
ASLN
Tags
Briefs
Movers
Phase 2 Trial
From
Benzinga
Opiant Pharma Starts Dosing In OPNT002 Mid-Stage Study For Alcohol Use Disorder
January 21, 2022
Tickers
OPNT
Tags
Market News
News
alcohol use disorder
From
Benzinga
FDA Clears Turning Point's IND For Elzovantinib + Aumolertinib Combo Regime In Lung Cancer Setting
January 20, 2022
Tickers
EQRX
TPTX
Tags
General
why it's moving
Phase 2 Trial
From
Benzinga
FDA Gives Green Signal To Compass Therapeutics' Mid-Stage Biliary Tract Cancer Trial In US
January 20, 2022
Tickers
CMPX
Tags
Penny Stocks
Trading Ideas
Benzinga
From
Benzinga
FDA clears Nuvation Bio's IND Application For NUV-868 In Advanced Solid Tumors
January 20, 2022
Tickers
NUVB
Tags
News
Health Care
Market News
From
Benzinga
KemPharm To Develop KP1077 As Lead SDX Candidate For Chronic Sleep Disorder
January 20, 2022
Tickers
KMPH
Tags
Phase 2 Trial
Briefs
Earnings
From
Benzinga
Leap Therapeutics Says DKN-01 Combo Regime Show Compelling Efficacy In Gastric Cancer Patients
January 19, 2022
Tickers
BGNE
LPTX
Tags
Benzinga
Biotech
LPTX
From
Benzinga
Cardiff Oncology Slumps On New Data From Lead Program In Metastatic Colorectal Cancer
January 19, 2022
Tickers
CRDF
Tags
CRDF
General
Briefs
From
Benzinga
RedHill Biopharma's Oral COVID-19 Treatment Improves Median Time To Viral RNA Clearance
January 13, 2022
Tickers
RDHL
Tags
Benzinga
Biotech
Penny Stocks
From
Benzinga
Vaxcyte Raises $100M Via Equity To Fund Development Of Lead Pneumococcal Vaccine Candidate
January 13, 2022
Tickers
PCVX
Tags
Trading Ideas
PCVX
Biotech
From
Benzinga
Ocugen Reveals Data From Bharat Biotech Partnered Covaxin Booster Dose
January 10, 2022
Tickers
OCGN
Tags
Market News
Health Care
News
From
Benzinga
Exclusive: Longeveron Kickstarts Its Mid-Stage Alzheimer's Disease Trial
January 05, 2022
Tickers
LGVN
Tags
Exclusives
Market News
Health Care
From
Benzinga
Annexon's Interim Mid-Stage Results On Huntington's Disease Candidate Fails To Cheer
January 05, 2022
Tickers
ANNX
Tags
Biotech
ANNX
Small Cap
From
Benzinga
Mereo BioPharma's Alvelestat Shows Improvement In COVID-19 Severity
December 22, 2021
Tickers
MREO
Tags
Health Care
News
Market News
From
Benzinga
PhaseBio Pulls Plug On Mid-Stage Hypertension Asset
December 21, 2021
Tickers
PHAS
Tags
Movers
Phase 2 Trial
Briefs
From
Benzinga
Adverum Outlines Development Plan For ADVM-022 Gene Therapy In Wet AMD
December 21, 2021
Tickers
ADVM
Tags
Health Care
News
Market News
From
Benzinga
CytomX Posts Interim Data From Phase 2 Trial Of CD71-Targeting Cancer Candidate
December 21, 2021
Tickers
ABBV
CTMX
Tags
Small Cap
Benzinga
Biotech
From
Benzinga
Can-Fite Shares Rally As Namodenoson Clears All Cancer Lesions In Liver Cancer Patient
December 20, 2021
Tickers
CANF
Tags
Penny Stocks
Trading Ideas
Biotech
From
Benzinga
Bellerophon Stock Surges After Positive Data From Sarcoidosis-Associated Pulmonary Hypertension Trial
December 17, 2021
Tickers
BLPH
Tags
Penny Stocks
Trading Ideas
Sarcoidosis
From
Benzinga
UniQure Shares Fall After Clinical Update From Huntington's Disease Gene Therapy Trial
December 16, 2021
Tickers
QURE
Tags
Health Care
News
Huntington's Disease
From
Benzinga
Arcturus Shares Shoot Higher After Additional Data From COVID-19 Vaccine Programs
December 16, 2021
Tickers
ARCT
BNTX
PFE
Tags
Small Cap
Benzinga
Biotech
From
Benzinga
Cullinan Oncology Posts Updated Data for CLN-081 in NSCLC EGFR Exon 20 Patients
December 16, 2021
Tickers
CGEM
Tags
CGEM
News
Health Care
From
Benzinga
Axcella Kickstarts Long COVID Phase 2 Clinical Trial
December 16, 2021
Tickers
AXLA
Tags
Market News
News
Health Care
From
Benzinga
Seres Posts Interim Microbiome Data Analysis From Failed Ulcerative Colitis Study
December 16, 2021
Tickers
MCRB
Tags
Trading Ideas
ulcerative colitis
Small Cap
From
Benzinga
Vaxart to Test Cross-Reactivity of its COVID-19 Oral Vaccine Against Omicron
December 16, 2021
Tickers
VXRT
Tags
Briefs
COVID/19 Vaccine
Phase 2 Trial
From
Benzinga
GeoVax Initiates Phase 2 Trial For COVID-19 Vaccine Booster
December 15, 2021
Tickers
GOVX
Tags
Biotech
Benzinga
COVID/19 Coronavirus
From
Benzinga
After Roche Walks Away, Atea Puts Break On Late-Stage COVID-19 Oral Antiviral Trial
December 15, 2021
Tickers
AVIR
RHHBF
RHHBY
RHHVF
Tags
Phase 3 Trial
COVID/19 Coronavirus
AVIR
From
Benzinga
Final Data Reaffirms Efficacy Of Pfizer's COVID-19 Antiviral Treatment
December 14, 2021
Tickers
PFE
Tags
Briefs
Phase 2 Trial
General
From
Benzinga
Aptose Shares Fall After HM43239 Data Featured At ASH Annual Meeting, Luxeptinib, APTO-253 Update
December 14, 2021
Tickers
APTO
Tags
Health Care
News
Market News
From
Benzinga
Gilead's CAR-T Yescarta Shows 78% Complete Response Rate In First-Line Lymphoma Patients
December 14, 2021
Tickers
GILD
Tags
Market News
News
GILD
From
Benzinga
< Previous
1
2
3
4
5
6
7
8
9
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms Of Service
.
Close